Tag: investing in Auxly Cannabis
Auxly Announces Closing of $20 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
Auxly’s Subsidiary KGK Science Receives Institutional Cannabis Research Licence from Health Canada
IIROC Trading Halt – XLY
Auxly Announces $10 Million Bought-Deal Public Offering
High-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness Consumer
Delta 9 Enters Into Agreement to Acquire Saskatchewan Retail Cannabis Store
Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects
